J. Gregory Swendsen is an active investor in the life sciences and applied technologies. Mr. Swendsen is a founder of SuperGen, Inc. a leading developer of anti-cancer drugs, a founder of Quark Pharmaceuticals, Inc., which was acquired by SBI Biotech in 2012, and served on the board of AMUR Pharmaceuticals prior to its sale to SuperGen. In July 2011 SuperGen acquired Astex Pharmaceuticals, Inc. In October 2013 Astex was acquired by Otsuko Holdings Co. for $886 million. Mr. Swendsen currently sits on the board of American Life Science Pharmaceuticals, Inc., a neurodegenerative disease company, and was an early investor in NovaBay Pharmaceuticals, Inc. (NYSE: NBY). He has raised over $500 million for pharmaceutical and biotech companies. He is currently an Advisor to ThoughtAI. Mr. Swendsen's portraits of professional tennis players can be viewed at www.tennisplayer.net. Under the name Gregory James, he has been a recording artist and composer for over 30 years, and is a 25 year member of NARAS. His label, Valence Records, Inc. is dedicated to releasing the finest in contemporary music.